Coverage
-
June 03, 2019
The Rosen Law Firm PA will serve as lead counsel in a proposed investor class action accusing Corbus Pharmaceutical Holdings Inc. and its officers of concealing negative results in clinical trials of its flagship drug, a Massachusetts federal judge decided Monday.
1 other articles on this case.
View all »